• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒高危人群中 EGCRISC 的表现和修饰。

Performance and modification of EGCRISC among hepatitis C virus high-risk groups.

机构信息

Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt.

出版信息

Epidemiol Infect. 2020 Feb 14;148:e28. doi: 10.1017/S0950268820000175.

DOI:10.1017/S0950268820000175
PMID:32054561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7026894/
Abstract

We have previously shown that the Egyptian Hepatitis C Virus Risk Score (EGCRISC), an Egyptian hepatitis C virus (HCV) risk-based screening tool, to be valid and cost-effective. Certain behaviours, occupations and diseases have been shown to be associated with an increased risk of exposure to HCV infection and constitute a major population reservoir of HCV infection. This study investigated the efficacy of EGCRISC in selected high-risk groups by testing 863 participants from four groups: slaughterhouse workers, illicit drug users (IDUs), female sex workers and human immune deficiency virus (HIV) patients. Data for this study were collected on EGCRISC and another pre-designed risk factor questionnaire. Sera were tested for HCV antibodies by ELISA. EGCRISC, at lower cut-off points, showed significantly good performance (P < 0.05) in all four groups except for females <45 years, but was reliable in detecting HCV cases (sensitivity: 84.21% and negative predictive value: 94.5%). Specific scores for IDUs and HIV patients were developed that showed high accuracy (P < 0.001). A modified EGCRISC for high-risk groups (EGCRISC-HRGs) was shown to be a valid tool that is recommended for use in high-risk populations if no other specific screening tool is available or universal screening is applied. EGCRISC for IDUs (EGCRISC-IDUs) and EGCRISC for HIV patients (EGCRISC-HIV) are useful tools for preselecting potentially HCV-infected cases for further testing in settings where serological analysis is not readily available or accessible.

摘要

我们之前已经证明,埃及丙型肝炎病毒风险评分(EGCRISC)是一种基于埃及丙型肝炎病毒(HCV)风险的筛查工具,具有有效性和成本效益。某些行为、职业和疾病已被证明与感染 HCV 的风险增加有关,是 HCV 感染的主要人群储库。本研究通过对来自四个群体的 863 名参与者(屠宰场工人、非法药物使用者(IDU)、性工作者和人类免疫缺陷病毒(HIV)患者)进行检测,研究了 EGCRISC 在选定高危人群中的疗效。本研究的数据是通过 EGCRISC 和另一个预先设计的风险因素问卷收集的。通过 ELISA 检测 HCV 抗体。EGCRISC 在所有四个群体(45 岁以下女性除外)中,在较低的截止点显示出明显的良好性能(P<0.05),但在检测 HCV 病例方面是可靠的(灵敏度:84.21%和阴性预测值:94.5%)。为 IDU 和 HIV 患者开发了特定的评分,显示出很高的准确性(P<0.001)。一种用于高危人群的改良 EGCRISC(EGCRISC-HRGs)被证明是一种有效的工具,如果没有其他特定的筛查工具可用或应用普遍筛查,则推荐在高危人群中使用。用于 IDU 的 EGCRISC(EGCRISC-IDUs)和用于 HIV 患者的 EGCRISC(EGCRISC-HIV)是用于预筛选可能感染 HCV 的病例的有用工具,以便在无法或无法获得血清学分析的情况下进行进一步检测。

相似文献

1
Performance and modification of EGCRISC among hepatitis C virus high-risk groups.丙型肝炎病毒高危人群中 EGCRISC 的表现和修饰。
Epidemiol Infect. 2020 Feb 14;148:e28. doi: 10.1017/S0950268820000175.
2
Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population.EGCRISC在埃及人群慢性丙型肝炎感染筛查及风险评估中的验证
PLoS One. 2016 Dec 21;11(12):e0168649. doi: 10.1371/journal.pone.0168649. eCollection 2016.
3
Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.2006 - 2013年中国广东省新进入美沙酮维持治疗的注射吸毒者中人类免疫缺陷病毒和/或丙型肝炎病毒检测及感染的趋势与因素:一项连续性横断面研究
BMJ Open. 2017 Jul 13;7(7):e015524. doi: 10.1136/bmjopen-2016-015524.
4
Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.注射吸毒者中人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒的合并感染
J Commun Dis. 2005 Mar;37(1):73-7.
5
Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.俄罗斯陶里亚蒂市注射吸毒者中的丙型肝炎病毒感染、艾滋病毒合并感染及相关风险
Int J STD AIDS. 2005 Nov;16(11):749-54. doi: 10.1258/095646205774763180.
6
Cost-effectiveness of EGCRISC application versus hepatitis C virus mass screening in Egypt.EGCRISC 应用与埃及丙型肝炎病毒大规模筛查的成本效益比较。
J Infect Public Health. 2019 May-Jun;12(3):442-444. doi: 10.1016/j.jiph.2018.08.004. Epub 2018 Sep 13.
7
Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.静脉吸毒者血源病毒合并感染及T淋巴细胞亚群的研究
World J Gastroenterol. 2007 Apr 28;13(16):2357-62. doi: 10.3748/wjg.v13.i16.2357.
8
Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.4 个国家级人类免疫缺陷病毒行为监测系统点的丙型肝炎病毒抗体快速检测试剂的性能。
Clin Infect Dis. 2011 Oct;53(8):780-6. doi: 10.1093/cid/cir499.
9
Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.注射吸毒者中人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒的合并感染
J Indian Med Assoc. 2009 Mar;107(3):144, 146-7.
10
Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.静脉注射吸毒者尸检材料中多种肝炎病毒感染的证据。
Ig Sanita Pubbl. 2005 Sep-Oct;61(5):435-50.

本文引用的文献

1
Hepatitis in slaughterhouse workers.屠宰场工人中的肝炎
World J Hepatol. 2019 Jan 27;11(1):37-49. doi: 10.4254/wjh.v11.i1.37.
2
Cost-effectiveness of EGCRISC application versus hepatitis C virus mass screening in Egypt.EGCRISC 应用与埃及丙型肝炎病毒大规模筛查的成本效益比较。
J Infect Public Health. 2019 May-Jun;12(3):442-444. doi: 10.1016/j.jiph.2018.08.004. Epub 2018 Sep 13.
3
Hepatitis C in Egypt - past, present, and future.埃及的丙型肝炎——过去、现在与未来
Int J Gen Med. 2016 Dec 20;10:1-6. doi: 10.2147/IJGM.S119301. eCollection 2017.
4
Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population.EGCRISC在埃及人群慢性丙型肝炎感染筛查及风险评估中的验证
PLoS One. 2016 Dec 21;11(12):e0168649. doi: 10.1371/journal.pone.0168649. eCollection 2016.
5
Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.丙型肝炎病毒感染的全球流行病学:丙型肝炎病毒基因型分布与传播的最新情况
World J Gastroenterol. 2016 Sep 14;22(34):7824-40. doi: 10.3748/wjg.v22.i34.7824.
6
Toward a simple risk assessment screening tool for HCV infection in Egypt.针对埃及 HCV 感染的简易风险评估筛查工具。
J Med Virol. 2016 Oct;88(10):1767-75. doi: 10.1002/jmv.24520. Epub 2016 Mar 21.
7
A Brief Screening Tool to Assess the Risk of Contracting HIV Infection Among Active Injection Drug Users.一种用于评估现用注射吸毒者感染艾滋病毒风险的简易筛查工具。
J Addict Med. 2015 May-Jun;9(3):226-32. doi: 10.1097/ADM.0000000000000123.
8
Variation of a test's sensitivity and specificity with disease prevalence.随着疾病流行率的变化,检测的灵敏度和特异性会发生变化。
CMAJ. 2013 Aug 6;185(11):E537-44. doi: 10.1503/cmaj.121286. Epub 2013 Jun 24.
9
Developing and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection.开发并验证一种用于识别丙型肝炎病毒感染风险增加的注射吸毒者的评分工具。
BMJ Open. 2012 Jan 4;2(1):e000387. doi: 10.1136/bmjopen-2011-000387. Print 2012.
10
Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population.评估一个风险评估问卷,以协助在普通人群中进行丙型肝炎筛查。
Euro Surveill. 2010 Apr 15;15(15):19539.